Most recently, Dr Cagle has served as senior vice president of R&D and chief scientific officer of Alcon Laboratories, a subsidiary of Alcon, Inc, an eye care company.
Dr Cagle has received his bachelor of science degree from Wayland College in Plainview, Texas. Dr Cagle earned both a master of science and a PhD from the University of North Texas in Denton, Texas.
Paul Hartung, president and CEO of Neuroptix, said: “We are delighted to have an industry veteran of Gerald Cagle’s caliber as part of our executive leadership at Neuroptix.
“He brings a wealth of industry experience of direct relevance to our mission of providing a new and reliable ocular-based diagnostic test for Alzheimer’s, and we look forward to his leadership as we bring our Sapphire technology toward clinical trials.”